Compare your options
GLP-1 Brand Medications
Compare Zepbound, Mounjaro, Wegovy and Ozempic side by side — active ingredient, dosing and monthly pricing through PrimeVida.
Zepbound
Brand-name weight-loss injection
Zepbound is brand-name tirzepatide approved for chronic weight management in eligible patients. It acts on GIP and GLP-1 pathways to reduce calorie intake and help you feel satisfied longer, giving you stronger support for losing weight and keeping it off.
Mounjaro
Brand-name tirzepatide
Mounjaro is brand-name tirzepatide, a once-weekly GIP/GLP-1 medication approved to improve blood sugar control in people with type 2 diabetes. It combines two incretin pathways in one treatment and is prescribed when your clinician determines the branded medication fits your medical needs.
Wegovy
Brand-name semaglutide
Wegovy is brand-name semaglutide approved for chronic weight management in eligible patients. It works through the GLP-1 pathway to help regulate appetite and calorie intake, making it easier to stay consistent with the habits that support long-term weight loss.
Ozempic
Brand-name semaglutide
Ozempic is a once-weekly brand-name semaglutide injection approved to improve blood sugar control in adults with type 2 diabetes. It works through the GLP-1 pathway and is prescribed when your clinician determines it is the right branded treatment for your metabolic health needs.
Prefer a compounded option?
Semaglutide and tirzepatide are available as injectable or sublingual RDT protocols, often at a lower monthly cost than brand medications.